SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-080071
Filing Date
2022-03-21
Accepted
2022-03-21 08:00:57
Documents
16
Period of Report
2022-03-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d252566d8k.htm   iXBRL 8-K 28862
2 EX-3.1 d252566dex31.htm EX-3.1 8399
3 EX-3.2 d252566dex32.htm EX-3.2 109027
4 EX-99.1 d252566dex991.htm EX-99.1 11811
8 GRAPHIC g252566g0321042047405.jpg GRAPHIC 3695
  Complete submission text file 0001193125-22-080071.txt   328713

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA reph-20220315.xsd EX-101.SCH 2869
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE reph-20220315_lab.xml EX-101.LAB 18740
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reph-20220315_pre.xml EX-101.PRE 11716
10 EXTRACTED XBRL INSTANCE DOCUMENT d252566d8k_htm.xml XML 3535
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 22754245
SIC: 2834 Pharmaceutical Preparations